Arax Advisory Partners’s Agilon Health AGL Stock Holding History

Arax Advisory Partners’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Buy	11,805 +11,531	+4,208%	+$755K	0.01%	1088
2026 Q1	$2.17K	Buy	274 +272	+13,600%	+$4.4K	﹤0.01%	3088
2025 Q4	$36	Sell	2 -50	-96%	-$970	﹤0.01%	3970
2025 Q3	$1.34K	Buy	+52	New	+$1.96K	﹤0.01%	3194
2024 Q4	–	Sell	-5	Closed	-$496	–	2423
2024 Q3	$496	Hold	5	–	–	﹤0.01%	2405
2024 Q2	$825	Buy	+5	New	+$712	﹤0.01%	2227

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Arax Advisory Partners's AGL Position: Q2 2026 in Review

Arax Advisory Partners increased its Agilon Health (AGL) stake by 4,208% in Q2 2026, buying an estimated $755K and bringing the position to 11,805 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #1088.

Arax Advisory Partners first reported a position in AGL in Q2 2024 and has held it in 6 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Arax Advisory Partners held 11,805 shares of Agilon Health worth $1.27M as of Q2 2026.
Arax Advisory Partners bought 11,531 Agilon Health shares in Q2 2026, an estimated $755K.
Agilon Health made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1088 holding.
Arax Advisory Partners first reported a position in Agilon Health in Q2 2024 and has held it in 6 quarters since.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.